LISTED pharmaceutical company Mayne Pharma has licensed rights to a generic topical dermatology product from topical preparations developer and manufacturer Encube Ethicals for distribution in the US.
This product adds to Mayne's branded and generic range with potential sales in excess of $40m per annum.
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Nov 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Nov 19